Current Clinical Trials

• HSR231585: PARALLEL PHASE III RANDOMIZED TRIALS OF GENOMIC-RISK STRATIFIED UNFAVORABLE INTERMEDIATE RISK PROSTATE CANCER: DE-INTENSIFICATION AND INTENSIFICATION CLINICAL TRIAL EVALUATION (GUIDANCE)
• HSR IRB HSR210410: A Study of Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer

 

• HSR IRB 20226: Evaluation of Circulating Tumor Cells for Patients with Cervical, Vaginal, Vulvar and Endometrial Cancers who receive Radiation Therapy

 

• HSR IRB 21063: A Randomized Phase III Trial of Two Standard Dose Fractionation Regimens for Adjuvant Vaginal Brachytherapy in Early Stage Endometrial Cancer

  

• HSR220263: Circulating Tumor Modified HPV DNA-Guided Radiotherapy De-intensification of the Elective Neck (RaDEN) in Squamous Cell Carcinoma of the Head and Neck